VASCEPA was associated with an increased risk (12% vs 10%) of bleeding in a double-blind, placebo-controlled trial. The incidence of bleeding was greater in patients receiving concomitant ...
Amarin Corporation plc (NASDAQ:AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today announced select preliminary unaudited 2025 financial ...
Oman’s shoreline has always been central to the country’s survival, economy and cultural identity. In Sur, a city in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback